You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antineoplastic

Showing 1 - 25 of 1,426
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)

Recruiting
  • Drug-Induced Acute Liver Injury
  • Bicyclol tablets
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Feb 2, 2023

Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))

Recruiting
  • Cancer
  • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
  • Jinan, Shandong, China
    Shandong Provincial Qianfoshan Hospital
Jul 18, 2022

Quality of Life, Oral Mucositis, Dental Plaque Trial in Barcelona (The probiotic to be used in the intervention corresponds to

Enrolling by invitation
  • Quality of Life
  • +5 more
  • The probiotic to be used in the intervention corresponds to PRODEFEN Plus manufactured by ITALFARMACO S.A. laboratory
  • Placebo
  • Barcelona, Spain
    University of Barcelona
Nov 9, 2023

Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

Recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 13, 2023

Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

Recruiting
  • Advanced Ovarian Carcinoma
  • +7 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
  • +2 more
Mar 7, 2023

Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

Not yet recruiting
  • Neoplasms
  • +2 more
  • Nivolumab Injection [Opdivo]
  • (no location specified)
Jul 19, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Digestive System Tumors, Thoracic Tumors Trial in Lille (Emotional skills, Short free talk and relaxation)

Recruiting
  • Digestive System Neoplasms
  • Thoracic Neoplasms
  • Emotional skills
  • Short free talk and relaxation
  • Lille, France
    Hôpital Calmette,CHU
Jul 4, 2022

COVID Trial in Vienna (Azithromycin 500 milligram (mg) oral Tablet, Placebo)

Completed
  • COVID
  • Azithromycin 500 milligram (mg) oral Tablet
  • Placebo
  • Vienna, Austria
    AKH Vienna, Department for Internal Medicine I, Oncology
Apr 6, 2022

Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 17, 2022

B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma
  • +4 more
  • (no location specified)
Dec 7, 2022

NSCLC, Antineoplastic Agents Trial in Edmonton (Experimental intervention)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Agents
  • Experimental intervention
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
May 23, 2022

Non Hodgkin Lymphoma Trial in New York, Clayton, Frankston (IPH6501)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • New York, New York
  • +2 more
Oct 12, 2023

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in

Recruiting
  • Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
  • Columbus, Ohio
  • +9 more
Aug 1, 2022

Amyloidosis Trial in Boston (blood collection, bone marrow collection)

Completed
  • Amyloidosis
  • blood collection
  • bone marrow collection
  • Boston, Massachusetts
    Boston Medical Center
Sep 8, 2021

Atrial Fibrillation in Patients With Cancer (MAFIC Study)

Recruiting
  • Cancer
  • Atrial Fibrillation
  • Low molecular weight heparin
  • Thessaloniki, Greece
  • +1 more
Feb 14, 2022

Reporting of Antibody-Drug Conjugate Associated Sepsis-related

Completed
  • Sepsis (SMQ)
  • +2 more
  • Antibody-Drug Conjugate
  • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
  • Changsha, Hunan, China
    Central South University
Jun 19, 2022

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Esophageal Squamous Cell Carcinoma Trial (Combination (S095033 + paclitaxel))

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Combination (S095033 + paclitaxel)
  • (no location specified)
Mar 28, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Concord, New South Wales, Australia
  • +4 more
May 30, 2023

Response to Antineoplastic Treatment of Metastatic Cancer

Recruiting
  • Metastatic Cancer
  • blood sample collection
  • Linz, Upper Austria, Austria
    Ordensklinikum Linz
Mar 9, 2021

Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

Recruiting
  • Hormone Receptor Positive Breast Carcinoma
  • +6 more
  • Liquid biopsy and CT scan
  • Bergame, Bergamo, Italy
  • +6 more
Apr 13, 2023

NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Mar 17, 2022

Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

Active, not recruiting
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Feb 28, 2022

Responsible Side Effects Management in Oncology

Completed
  • Pharmacovigilance
  • +2 more
    • Zagreb, Croatia, Europe, Croatia
      UHC Sestre milorsdnice
    Nov 4, 2020